Approvals/TGA/PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

Approved

STANDARD

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 50f860de5f0fc1dd
Product Name: PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack
Artg Id: 377572
Artg Name: PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2022-01-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ab0c3e9b9c7ef8e2eef7f1a85c76c33f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/bcf4457b8d23b5ccd4553d82df53821b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

50f860de5f0fc1dd

Type

Standard